Testosterone/dutasteride
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 04:50, 19 December 2017 (←Created page with '{{Drugbox | image = | width = | caption = <!--Combo data--> | type = combo | drug_name = | component1 = Testosterone | class1 = Androgen | component2 =...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
| Combination of | |
|---|---|
| Testosterone | Androgen |
| Dutasteride | 5α-Reductase inhibitor |
| Clinical data | |
| Other names | Dutasteride/testosterone |
Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]
References
External links
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles